These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 28030783)

  • 21. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study.
    Vieites B; López-García MÁ; Martín-Salvago MD; Ramirez-Tortosa CL; Rezola R; Sancho M; López-Vilaró L; Villardell F; Burgués O; Fernández-Rodriguez B; Alfaro L; Peg V
    Clin Transl Oncol; 2021 Jul; 23(7):1377-1385. PubMed ID: 33517542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
    Osako T; Iwase T; Kimura K; Horii R; Akiyama F
    Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
    Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
    Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive non-sentinel axillary lymph nodes in breast cancer with 1-2 sentinel lymph node metastases.
    Zheng J; Cai S; Song H; Wang Y; Han X; Wu H; Gao Z; Qiu F
    Medicine (Baltimore); 2018 Nov; 97(44):e13015. PubMed ID: 30383658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
    Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
    J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can clinicopathological factors improve the prediction of metastasis to nonsentinel lymph nodes in patients with breast cancer?
    García-Mejido JA; Sánchez-Sevilla M; González-Martínez J; Fernández-Palacín A; Sainz-Bueno JA
    Cir Cir; 2022; 90(4):473-480. PubMed ID: 35944438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors of non-sentinel lymph node metastasis in breast cancer with 1-2 sentinel lymph node macrometastases underwent total mastectomy: a case-control study.
    Huang Z; Wu Z; Zou QQ; Xie YJ; Li LH; Huang YP; Wu FM; Huang D; Pan YH; Yang JR
    World J Surg Oncol; 2023 Apr; 21(1):125. PubMed ID: 37024930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.
    Banerjee SM; Williams NR; Davidson TI; El Sheikh S; Tran-Dang M; Davison S; Ghosh D; Keshtgar MR
    Eur J Surg Oncol; 2016 May; 42(5):641-9. PubMed ID: 26979647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
    Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
    Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
    Huxley N; Jones-Hughes T; Coelho H; Snowsill T; Cooper C; Meng Y; Hyde C; Mújica-Mota R
    Health Technol Assess; 2015 Jan; 19(2):v-xxv, 1-215. PubMed ID: 25586547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is it Possible to Predict Non Sentinel Node Positivity on the Basis of mRNA Copy Numbers of CK19 Receptor in Breast Cancer?
    Sharma RD; Sharmin A; Sinha A; Solomon A; Huynh I; Alani A; Nagarajakumar A; Kasem A; Doddi S
    Clin Breast Cancer; 2021 Oct; 21(5):e561-e564. PubMed ID: 33712365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.
    Reynders A; Brouckaert O; Smeets A; Laenen A; Yoshihara E; Persyn F; Floris G; Leunen K; Amant F; Soens J; Van Ongeval C; Moerman P; Vergote I; Christiaens MR; Staelens G; Van Eygen K; Vanneste A; Van Dam P; Colpaert C; Neven P
    Breast; 2014 Aug; 23(4):453-9. PubMed ID: 24768478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.
    Tamaki Y; Sato N; Homma K; Takabatake D; Nishimura R; Tsujimoto M; Yoshidome K; Tsuda H; Kinoshita T; Kato H; Taniyama K; Kamio T; Nakamura S; Akiyama F; Noguchi S;
    Cancer; 2012 Jul; 118(14):3477-83. PubMed ID: 22252672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-step nucleic acid amplification (OSNA): where do we go with it?
    Tamaki Y
    Int J Clin Oncol; 2017 Feb; 22(1):3-10. PubMed ID: 27549784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraoperative sentinel lymph node assessment in breast cancer: a comparison of rapid diagnostic method based on CK19 mRNA expression and imprint cytology.
    Pathmanathan N; Renthawa J; French JR; Edstrom-Elder E; Hall G; Mahajan H; Teh C; Bilous MA
    ANZ J Surg; 2014 Oct; 84(10):730-4. PubMed ID: 24899463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.
    Ohi Y; Umekita Y; Sagara Y; Rai Y; Yotsumoto D; Matsukata A; Baba S; Tamada S; Matsuyama Y; Ando M; Sagara Y; Sasaki M; Tsuchimochi S; Tanimoto A; Sagara Y
    Br J Cancer; 2012 Oct; 107(8):1239-43. PubMed ID: 22929881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
    Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
    Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.
    Deambrogio C; Castellano I; Paganotti A; Zorini EO; Corsi F; Bussone R; Franchini R; Antona J; Miglio U; Sapino A; Antonacci C; Boldorini R
    J Clin Pathol; 2014 Aug; 67(8):702-6. PubMed ID: 24906358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method.
    Di Filippo F; Giannarelli D; Bouteille C; Bernet L; Cano R; Cunnick G; Sapino A
    J Exp Clin Cancer Res; 2015 Nov; 34():136. PubMed ID: 26538019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.